SCHEMBL8328339

SCHEMBL8328339

CC(C)(C)OC(=O)NC(C(=O)Nc1ccc(C(F)(F)F)cc1)c1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSS P25774 1/20 0.57
CTSK P43235 1/20 0.57
RORC P51449 2/20 0.47
RAB9A P51151 2/20 0.47
NPC1 O15118 1/20 0.47
FNTA P49354 1/20 0.47
FNTB P49356 1/20 0.47
S1PR3 Q99500 1/20 0.46
TACR1 P25103 1/20 0.45
MAPT P10636 2/20 0.44
MEN1 O00255 1/20 0.44
HTT P42858 1/20 0.44
KMT2A Q03164 1/20 0.44
SCN9A Q15858 1/20 0.44
TP53 P04637 1/20 0.44
POLB P06746 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
BACE1 P56817 2/20 0.44
PPARG P37231 1/20 0.43
PPARA Q07869 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8338149 0.89 CTSK (0.66) CTSSCTSKS1PR3MAPTSCN9A
SCHEMBL31048635 0.89 CTSK (0.66) CTSSCTSKS1PR3MAPTSCN9A
SCHEMBL4597368 0.88 CTSS (0.59) CTSSCTSKS1PR3MEN1HTT
SCHEMBL4597362 0.88 CTSS (0.59) CTSSCTSKS1PR3MEN1HTT
SCHEMBL8336482 0.87 SMN1; SMN2 (0.58) CTSSCTSKRAB9AS1PR3TACR1
SCHEMBL8337364 0.87 SMN1; SMN2 (0.58) CTSSCTSKRAB9AS1PR3TACR1
SCHEMBL8336006 0.87 CTSS (0.56) CTSSCTSKS1PR3MAPTKMT2A
SCHEMBL8336332 0.86 CTSS (0.60) CTSSCTSKFNTAFNTBS1PR3
SCHEMBL8337402 0.85 CTSS (0.59) CTSSCTSKS1PR3MAPTMEN1
SCHEMBL8338474 0.85 CTSS (0.59) CTSSCTSKRORCRAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004022528-A2 ARYLGLYCINE DERIVATIVES AND THEIR USE AS GLYCINE TRANSPORT INHIBITORS NPS ALLELIX CORP. (CA) 2004-03-18 WO disclosed